Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized-Reference-Cited by-同舟云学术

Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized

Published:1999-06 Issue:4 Volume:105 Page:1109-1113
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Astermark Jan,Petrini Pia,Tengborn Lilian,Schulman Sam,Ljung Rolf,Berntorp Erik

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.1999.01463.x/fullpdf

Reference18 articles.

1. Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculoskeletal manifestations of haemophilia A and B;Ahlberg;Acta Orthopaedica Scandinavica,1965

2. A longitudinal study of orthopaedic outcomes for severe factor VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group;Aledort;Journal of Internal Medicine,1994

3. Methods of hemophilia care delivery; regular prophylaxis vs. episodic treatment;Berntorp;Haemophilia,1995

4. Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations;Berntorp;Haemophilia,1996

5. Central venous access devices in children with hemophilia: an up-date;Blanchette;Blood Coagulation and Fibrinolysis,1997

Cited by 258 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health‐related quality of life in patients with severe haemophilia A;Haemophilia;2023-05-30

2. Characteristics of BAY 2599023 in the Current Treatment Landscape of Hemophilia A Gene Therapy;Current Gene Therapy;2023-04

3. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia;Expert Review of Hematology;2023-03-15

4. Adherence to prophylaxis and bleeding outcome: A multicenter Nigerian study;PLOS ONE;2023-02-02

5. Considerations for shared decision management in previously untreated patients with hemophilia A or B;Therapeutic Advances in Hematology;2023-01